Our findings identify accumulation of FGF23 as novel mechanism of pulmonary vascular remodeling in PAH. Targeting dysregulated Klotho/FGF23 signaling may present a promising therapeutic strategy in elderly patients.
Perret et al. (Fri,) studied this question.